LXEO in the 13F filings
Lexeo Therapeutics Inc · CUSIP 52886X107
- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 2 Sep 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 16
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 1 listed it in both
- Shares listed
- 17,079,373
- combined, among listed positions
- Reported value
- $80m
- combined, at the quarter end
AllianceBernstein LP. Values in this filing are at the previous quarter end's prices; its share count is the quarter end's.
Among the 91 comparable managers: 10 buyers (opened or added shares) and 10 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was -785,209.
Managers listing LXEO in Q2 2026
16 of 16 holders
Largest increases and reductions, by shares
Increases
- Millennium Management LLCexisting position · 2,833,622 shares now+1,220,842
- Balyasny Asset Management LLCexisting position · 2,412,742 shares now+823,157
- Renaissance Technologies LLCnew position · 250,365 shares now+250,365
- Fidelity (FMR LLC)existing position · 141,146 shares now+116,758
- Walleye Capital LLCnew position · 73,868 shares now+73,868
Reductions
- Janus Henderson Group Ltdexisting position · 3,954,691 shares now-1,021,738
- Woodline Partners LPexisting position · 2,500,532 shares now-250,000
- ExodusPoint Capital Management LPexisting position · 27,880 shares now-84,292
- AQR Capital Management LLCexisting position · 256,661 shares now-82,962
- Squarepoint Ops LLCexisting position · 294,774 shares now-24,316
New positions and exits
New (2)
Exited (4)
- Point72 Asset Management LPwas $9.6m
- Two Sigma Investments LPwas $1.0m
- Susquehanna International Group LLPwas $270k
- Schonfeld Strategic Advisors LLCwas $139k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2023 | 2 | $65m | 2 | 0 |
| Q1 2024 | 2 | $79m | 1 | 0 |
| Q2 2024 | 3 | $104m | 2 | 0 |
| Q3 2024 | 3 | $64m | 2 | 0 |
| Q4 2024 | 2 | $20m | 1 | 1 |
| Q1 2025 | 1 | $3.4m | 0 | 1 |
| Q2 2025 | 2 | $14m | 1 | 0 |
| Q3 2025 | 3 | $64m | 1 | 0 |
| Q4 2025 | 2 | $86m | 16 | 9 |
| Q1 2026 | 1 | $16m | 10 | 12 |
| Q2 2026 | 1 | $12m | 10 | 10 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
LXEO and GILD →LXEO and AMGN →LXEO and ARGX →Choose a stock to compare with LXEO →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own LXEO, latest filings →Back to the 13F Explorer →